ANDA 89021, held by Naska. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 89021 (Cyproheptadine Hydrochloride), held by Naska, was first approved by FDA on Dec 21, 1987, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride2MG/5ML ยท syrup;oral | Cyproheptadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters